| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 08/25/2004 | EP1448542A1 6-hydroxy isoflavones, derivatives and medicaments involving same |
| 08/25/2004 | EP1448535A1 Benzamide and heteroarylamide as p2x7 receptor antagonists |
| 08/25/2004 | EP1448531A1 3-cyanoquinolines as inhibitors of egf-r and her2 kinases |
| 08/25/2004 | EP1448526A1 Piperidine-based mch antagonists for treatment of obesity and cns disorders |
| 08/25/2004 | EP1448525A1 Novel piperidine derivatives as modulators of chemokine receptors |
| 08/25/2004 | EP1448524A1 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially ccr5) |
| 08/25/2004 | EP1448523A1 Heterocyclic compounds and methods of use |
| 08/25/2004 | EP1448521A1 Derivatives of andrimide and moiramide b having antibacterial properties |
| 08/25/2004 | EP1448513A1 Biphenyl-derivatives as p38-kinase inhibitors |
| 08/25/2004 | EP1448235A1 Pharmaceutical compositions of 5,7,14-triazatetracyclo 10.3.1.0(2,11).0(4,9)]-hexadeca-2(11)3,5,7,9-pentaene |
| 08/25/2004 | EP1448216A2 Methods for epitope-specific and cytokine/anticytokine combination immunotherapies for modulation of pathogenic immune responses in immune mediated diseases |
| 08/25/2004 | EP1448214A2 Ginger extract preparation |
| 08/25/2004 | EP1448212A1 Mint extract pharmaceutical compositions |
| 08/25/2004 | EP1448205A2 Combinations for the treatment of immunoinflammatory disorders |
| 08/25/2004 | EP1448199A1 Benzimidazoles useful as protein kinase inhibitors |
| 08/25/2004 | EP1448195A1 N-adamantylmethyl derivates and intermediates as pharmaceutical compositions and processes for their preparation |
| 08/25/2004 | EP1448194A1 Apomorphine-containing dosage form for ameliorating male erectile dysfunction |
| 08/25/2004 | EP1448180A1 Para-amino benzoic acids as integrin antagonists |
| 08/25/2004 | EP1448150A2 Treatment of hyperproliferative diseases using active vitamin d analogues |
| 08/25/2004 | EP1343764B1 Urea and urethane derivatives as integrin inhibitors |
| 08/25/2004 | EP1270555B1 Method for oxidizing a thioether group into a sulfoxide group |
| 08/25/2004 | EP1185612B1 Bioreactor design and process for engineering tissue from cells |
| 08/25/2004 | EP1169337B1 Steroid nitrates for the treatment of oxidative injury and endothelial dysfunction |
| 08/25/2004 | EP1025094B1 Substituted indan derivatives |
| 08/25/2004 | CN1524082A Beta-amino tetrahydroimidazo (1,2-a) pyrazines and ahydrotrioazolo (4,3-a) pyrazines as dipeptidyl idase inhibitors for the treatment or prevention of diabetes |
| 08/25/2004 | CN1524080A Phthalatyinone-piperidino-derivatives as pde4 inhibitors |
| 08/25/2004 | CN1524079A Novel sulfamides and their use as endothelin receptor antagonists |
| 08/25/2004 | CN1524078A Antagonists of mcp-1 function and methods of use thereof |
| 08/25/2004 | CN1523989A Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 08/25/2004 | CN1523988A Use of nk-1 receptor antagonists for the treatment of brain, spinal or nerve injury |
| 08/25/2004 | CN1523987A Immune response modifiers for the treatment of periodontal disease |
| 08/25/2004 | CN1523981A A pharmaceutical tablet having a high API content |
| 08/25/2004 | CN1523099A Health care medicinal liquor |
| 08/25/2004 | CN1523041A Bulgaria inquinans polysaccharide, method for preparing the same and pharmaceutical composition using the compound as active component |
| 08/25/2004 | CN1523015A 2-amino-6-(2-substituted-4-phenoxy)-substituted-pyridines |
| 08/25/2004 | CN1522761A Composite hepatitis B vaccine for treatment and its preparation method |
| 08/25/2004 | CN1522738A Gastric disease drug and its preparation method |
| 08/25/2004 | CN1522737A Stomatocace therapeutic pharmaceutical and its preparation method |
| 08/25/2004 | CN1522735A Colitis therapeutic traditional Chinese medicine |
| 08/25/2004 | CN1522734A Quick-effective toothache liquid |
| 08/25/2004 | CN1522732A Traditional Chinese medicine preparation for treating stomach disease |
| 08/25/2004 | CN1522729A Acne eliminating cathartic pill preparation method |
| 08/25/2004 | CN1522726A Novel schisandra fruit soft capsule formulation and its preparation method |
| 08/25/2004 | CN1522711A Enterobacteria containing tablet |
| 08/25/2004 | CN1522700A Furfuryl sterol drop pills and method for making same |
| 08/25/2004 | CN1522694A Medicine for treating dizziness and making method thereof |
| 08/25/2004 | CN1522687A Oral health product using adhesive material as carrier |
| 08/25/2004 | CN1522682A Pharmaceutical lip polishing lipstick and method for making same |
| 08/25/2004 | CN1163512C Humanized neutralizing genetic engineering Fab antibody of anti hepatitis A virus |
| 08/25/2004 | CN1163486C Guanidinylamino heterocycle compounds useful as alpha-2 adrenoceptor agonists |
| 08/25/2004 | CN1163466C Substituted oxobutyric acid derivative as matrix metalloprotease inhibitor |
| 08/25/2004 | CN1163263C Polypeptide medicine as oral spray |
| 08/25/2004 | CN1163256C Chinese herb medicine composition for curing chronic colitis, gastritis and gastric ulcer |
| 08/25/2004 | CN1163251C Drug for treating gastritis |
| 08/25/2004 | CN1163248C Garlic health care liquid |
| 08/25/2004 | CN1163244C Navel-adminstering formulation for curing intractable ascites of liver cirrhosis |
| 08/25/2004 | CN1163243C Prepared pill of traditional Chinese medicine for treating hepatism |
| 08/25/2004 | CN1163242C Heart nourishing capsule and its preparing process |
| 08/25/2004 | CN1163227C Application of tanhin polyphenolic B magnesium in preparing medicine for treating chronic hepatosis |
| 08/24/2004 | US6780968 Neurokinin-2 (nk-2) antagonists useful in the treatment or prevention of disorders of the central nervous system, inflammatory diseases, asthma, or pain |
| 08/24/2004 | US6780882 Substituted benzimidazole dosage forms and method of using same |
| 08/24/2004 | US6780881 Freeze-dried pantoprazole preparation and pantoprazole injection |
| 08/24/2004 | US6780874 Autoimmune disease; antiinflammatory agents; antiproliferative agent |
| 08/24/2004 | US6780873 Urea substituted imidazoquinolines |
| 08/24/2004 | US6780870 Treatment of the pain (both chronic and acute), fever and inflammation of a variety of conditions and diseases mediated by cox-2 |
| 08/24/2004 | US6780869 Selective inhibitor of cox-2; antiinflammatory agent |
| 08/24/2004 | US6780862 Such as amino-indazoles for treatment of central nervous system disorders |
| 08/24/2004 | US6780859 For therapy of diabetes, obesity, impaired glucose tolerance, gastrointestinal disorders, hypertriglyceridemia, hypercholesteolemia, atherosclerotic disorders, or cardiovascular disorders |
| 08/24/2004 | US6780844 Calcium phosphopeptide complexes |
| 08/24/2004 | US6780640 Human carboxypeptidases and polynucleotides encoding the same |
| 08/24/2004 | US6780628 Enzyme treatment |
| 08/24/2004 | US6780623 Low temperature expression cDNAs encoding fructan synthesizing enzymes and method of isolating the same |
| 08/24/2004 | US6780609 High bone mass gene of 1.1q13.3 |
| 08/24/2004 | US6780442 Efficient method for producing compositions enriched in anthocyanins |
| 08/24/2004 | US6780436 Solid oral pharmaceutical formulation of modified release that contains an acid labile benzimidazole compound |
| 08/24/2004 | US6780435 Pellet comprising inert core component, omeprazole, surface active agent, filler, alkaline agent, binder and single layer of enteric coating |
| 08/24/2004 | US6780414 Methods of identifying bacterial genes that are incompatible with bacterial pathogenicity, and the use of such genes, such as cada, to reduce pathogenicity in a bacteria or to combat pathogenic bacterial infections |
| 08/24/2004 | CA2098256C Bile acid derivatives, process for their preparation and use of these compounds as pharmaceuticals |
| 08/19/2004 | WO2004069806A2 Substituted 2-aminoimidazoles, method for the production thereof, their use as a medicament or as a diagnostic reagent, and medicament containing these compounds |
| 08/19/2004 | WO2004069798A1 Melanin-concentrating hormone receptor antagonists containing piperidine derivatives as the active ingredient |
| 08/19/2004 | WO2004069294A1 Injectable gel-forming compositions based on cross-linked and non-cross-linked polymers and the use thereof |
| 08/19/2004 | WO2004069179A2 Improved thickened beverages for dysphagia |
| 08/19/2004 | WO2004069165A2 Methods and compositions for the treatment of gastrointestinal disorders |
| 08/19/2004 | WO2004069142A2 Anti-candida agents for the treatment of prion diseases |
| 08/19/2004 | WO2003092688A3 Heterocyclic derivatives as opioid modulators |
| 08/19/2004 | WO2003053364A3 Methods and compositions in treating pain and painful disorders using 1465,1587, 2146, 2207, 32838, 336 and 52908 |
| 08/19/2004 | WO2003049702A8 Vanilloid receptor ligands and their use in treatments |
| 08/19/2004 | WO2002092006A3 Nucleic acid-based compounds and methods of use thereof |
| 08/19/2004 | US20040162433 Lipoxin A4 analogs |
| 08/19/2004 | US20040162426 TNF (tumor necrosis factor); for treating conditions such as rheumatoid and osteoarthritis, corneal, epidermal or gastric ulceration; tumor metastasis or invasion; periodontal disease and bone disease |
| 08/19/2004 | US20040162422 adenosine derivatives having an acetylene group in the 4' position, which are adenosine A1 agonists; treating ischaemic heart disease, peripheral vascular disease or stroke or patient suffering pain, a CNS disorder, sleep apnoea or emesis |
| 08/19/2004 | US20040162417 Nucleotide sequences coding metalloenzyme for use in detergents, therapeutic, cosmetics, leather processing, solubilizing or softening agents, foods, meat modifiers, feeds and oil and fat seperating agents |
| 08/19/2004 | US20040162341 Sulphonated dehydrogenated sylvate, the preparation and use |
| 08/19/2004 | US20040162329 Structural carotenoid analogs for the inhibition and amelioration of disease |
| 08/19/2004 | US20040162314 Enzyme inhibitors of phosphordiesterase 4 having minimal side effects; antiinflammatory agents; antiallergens; asthma; neurodegenerative disorders; antidiabetic agents; pain; anti-tumor, -carcinogenic and -arthritic agents |
| 08/19/2004 | US20040162313 Heterocyclic derivatives |
| 08/19/2004 | US20040162310 Tetrahydropyridoethers |
| 08/19/2004 | US20040162304 Estrogen receptor modulators |
| 08/19/2004 | US20040162291 For therapy of cardiovascular disorders and erectile dysfunction |
| 08/19/2004 | US20040162290 For therapy of cancer, benign prostatic hypertrophy or myoma of the uterus, endometriosis, polycystic ovarian disease, uterine fibroids or precocious puberty, lupus erythematosis, irritable bowel syndrome, premenstrual syndrome, hirsutism |